
Scan how Rocket Lab fits into the wider space and defense opportunity set by lining it up against our hand picked 94 robotics and automation stocks powering the next wave of orbital and automation demand.
To own Rocket Lab, you need to believe the business can turn its high Electron launch cadence and expanding space systems work into durable contracts while eventually making Neutron pay off. The near term story still revolves around steady mission execution and backlog quality more than day to day share price swings.
The recent Neutron delay into early 2027 keeps the first successful flight as the key short term catalyst and also the main risk. Catching the carbon dome defect in testing protects the program, yet it extends the period of heavy R&D spend, negative free cash flow and potential funding or dilution pressure if conditions tighten.
The shipment of Neutron's second stage and thrust module to Virginia is the announcement that matters most here. Hardware now moving to the pad for systems testing gives investors a concrete sign that Neutron is progressing from design to integration, even as the inaugural launch date shifted into 2027.
That step does not change the earnings timing management has linked to Neutron's first successful flight, but it makes the path more visible. For you, the trade off is clear: every milestone at the launch site can de risk execution and future contract wins, while any further hiccups or cost overruns could stretch the cash burn period and raise the odds of extra capital raises.
Rocket Lab’s current analyst script points to revenues of US$2.0b and earnings of US$166.3m by 2029. This implies about 37.0% yearly top line growth and a swing in profitability of roughly US$332m from today’s earnings loss of US$165.5m.
Uncover why Rocket Lab's fair value indicates a potential 80% upside to its current price before that discount starts to close.
Some of the lowest Rocket Lab forecasts lean hard on Neutron execution risk. Those analysts were working with revenue growth closer to 34.5% and potential 2029 earnings near US$179.4 million or even a US$160.1 million loss. That is a much harsher story. Treat this HawkEye 360 launch as a fresh data point and compare several viewpoints.
Explore 18 other Rocket Lab fair value estimates, including one that suggests as much as 72% downside from the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If you want to cross check Rocket Lab against other opportunities, a quick sweep through the Simply Wall St Screener can surface stocks with very different risk and reward profiles.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com